Skip to main content

Table 2 Descriptive statistics of healthcare utilization, palliative care and therapy

From: Factors related to and economic implications of inhospital death in German lung cancer patients - results of a Nationwide health insurance claims data based study

  Entire sample Inhospital death No Inhospital death p-valuec
n (%)
Healthcare utilization a
12,457 (100) 6965 (55.9) 5492 (44.1)  
 Number of hospital days (SD) 9.8 (8.2) 10.9 (8.7) 8.4 (7.3) < 0.0001
 Number of outpatient doctor visits (SD) 3.0 (2.4) 3.1 (2.6) 2.8 (2.2) < 0.0001
 Number of outpatient hospital visits (SD) 0.01 (0.1) 0.01 (0.1) 0.02 (0.1) 0.0559
Palliative Care
 Inpatient palliative care N (%) 1994 (16.0) 1256 (18.0) 738 (13.4) < 0.0001
 Outpatient palliative care N (%) 2388 (4.3) 111 (1.6) 425 (7.7) < 0.0001
Chemotherapy in last 30 days of life (%) 3009 (24.2) 2090 (30.0) 919 (16.7) < 0.0001
Treatment b
 No treatment N (%) 2124 (17.1) 896 (12.9) 1228 (22.4) < 0.0001
 Chemotherapy N (%) 2990 (24.0) 1745 (25.1) 1245 (22.7) 0.002
 Radiotherapy N (%) 967 (7.8) 512 (7.4) 455 (8.3) 0.0532
 Surgery N (%) 715 (5.7) 421 (6.0) 294 (5.4) 0.0996
 Chemotherapy and Radiotherapy N (%) 3169 (25.4) 1867 (26.8) 1302 (23.7) < 0.0001
 Chemotherapy and Surgery N (%) 1016 (8.2) 632 (9.1) 384 (7.0) < 0.0001
 Radiotherapy and Surgery N (%) 301 (2.4) 158 (2.3) 143 (2.6) 0.2263
 All three types N (%) 1175 (9.4) 734 (10.5) 441 (8.0) < 0.0001
  1. a Healthcare utilization by month survived between diagnosis and death
  2. b Information if patients received this combination of treatments at any time of the observation period. Number or order of treatments was not considered
  3. cp-values from Wilcoxon U-test for healthcare utilization, and from Chi2 test for treatment and palliative care